Computer-Controlled Type METI-IVD
Technical Parameter
Supply Voltage: AC 220±10%, 50HZ
Supply Current: 4.2A (Dual Output Maximum)
Microwave Frequency: 2450MHZ±50MHZ
Power: 0 ~ 99W (continuously adjustable)
Time of Therapy: 0 to 60 minutes
Temperature Range: 15°C~100°C
Microwave Output: Dual Output
Output Mode: Continuous Pulse Dual-Mode
Device Interface:
Two Microwave Output Interface
Two Temperature Surveying Input Interface
Four USB Interface
One RJ45 Network Interface
Standard: YZB/Guo 1346-2003
Security Category: Class I, Type B
Ambient Temperature: 0°C-40°C
Relative Humidity: ≤85%
Characteristics
Direct Computer Operation.
It can conduct real-time communication with image documentation equipment such as B-type ultrasonography and CT. Operators can randomly select and save eight images. The management system of case files and the graphics workstation can facilitate clinical research and case file archiving.
With the latest image processing technology, it can get clearer image, more convenient comparison of images and more accurate diagnose.
Several sets of diagnosis and treatment programme from eminent experts are pre-installed for doctors' reference.
Remote Guidance and Control of Operation.
By pass temperature measurement, stable and accurate.
Multi-Channel Microwave Output: It can eliminate the tumor around 7 cm in diameter. According to clinical needs, emission source would be increased with multiple cutter head for the ablation of larger solid tumors.
bio-equip.cn
Fuzhong Medical High-Tech, formerly known as Nanjing New Technology Application Research Institute Co. Ltd., belongs to Fuzhong Group which is one of the top 500 enterprises and national high and new technology enterprise. With abundant financial resources, formidable marketing team, top-end sale channels, good reputation and abundant products, Fuzhong Medical Hi-Tech owns 8 subsidiary companies and 46 offices in first-tier cities including Beijing, Shanghai and Guangzhou. We have more than 1000 employees, in which 30% with master degree or above and 10% with doctor degree or above. Presently, Fuzhong Medical Hi-Tech has already developed into International renowned large-scale medical equipment enterprise in researching, developing, manufacturing and selling.
Fuzhong Medical Hi-Tech is the only strategic partner with National Ministry of Health and China Primary Health Care Foundation on several medical equipments including tumor coagulation equipment, varicose veins remedial equipment and remote patient monitoring system. Since 2010, Fuzhong Medical Hi-Tech cooperated with National Ministry of Health to launch the clinical research topic of Intratumor Target Immunity Radiotherapy Applied Together with Microwave Ablation. In the course of this research, the self-owned intellectual property rights product, known as New Generation of Computer Controlled Microwave Tumor Remedial Equipment, has been applied in over 100 first rate hospitals including 301 Hospital, 303 Hospital, Shanghai Huashang Hospital, Shanghai Renji Hospital and General Hospital of Guangzhou Military Command of PLA.
Other self-owned intellectual property rights Hi-Tech Medical products are including Cold Circulation Microwave Equipment, Microwave Coagulation Intracavitary Treatment for Varicose Veins, METI-IV Microwave Remedial Equipment and DGY-2 Computer Enema Therapeutic Equipment. Fuzhong Medical Hi-Tech gained business license of medical equipment in February, 2010. Our agent products are including Class medical devices, Class medical electronic devices, medical optics instruments, accessories and endoscopes, somascopes and accessories, medical laser devices, medical high-frequency devices, physiotherapy and related recovery devicesmedical X-ray devices, clinical inspection and analysis devices as well as those devices and instruments applied by operating room, emergency room and consulting room. Presently, we have established strategic partnership with EPOS and Vitaphone for becoming the national exclusive agent for remote patient monitoring system.
Fuzhong Medical Hi-Tech aims to be the front-runner in the industry of medical equipment and will realize going public in 2014.
中文
